trials:
  - id: 'NCT04818619'
    name: 'TIGIT in Patients With Chronic Myeloid Leukemia'
  - id: 'NCT04150965'
    name: 'Immuno-Oncology Drugs Elotuzumab, Anti-LAG-3 and Anti-TIGIT'
  - id: 'NCT05607563'
    name: 'A Study of PM1009 (Anti-TIGIT/PVRIG) in Patients With Advanced Tumours'
  - id: 'NCT05394168'
    name: 'A Phase I Clinical Study of HLX53 in Advanced/Metastatic Solid Tumors'
  - id: 'NCT07171307'
    name: 'Treg Effector Function and Th2/Treg Ratio in Allergic Conjunctivitis: Effect of Desensitization Therapy'
  - id: 'NCT04995523'
    name: 'A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC'
  - id: 'NCT03119428'
    name: 'A Study of OMP-313M32 in Subjects With Locally Advanced or Metastatic Solid Tumors'
  - id: 'NCT04500678'
    name: 'Impact of Metformin on Immuno-virologic Parameters in HIV'
  - id: 'NCT05483400'
    name: 'Open Label Phase 2 Basket Trial With Atezolizumab and Tiragolumab in Solid Tumors'
  - id: 'NCT05390528'
    name: 'A Study Evaluating the Safety, Tolerability, Pharmacokinetic and Efficacy of HLX301(TIGIT×PDL1 Bispecific) in Locally Advanced/Metastatic Solid Tumors or Lymphoma'
  - id: 'NCT06250036'
    name: 'Zimberelimab Anti-PD1 +/- Domvanalimab in Resectable Mmrd Gastric Cancer'
  - id: 'NCT05653284'
    name: 'A Study of AK130 in Patients With Advanced Malignant Tumors'
  - id: 'NCT05102214'
    name: 'HLX301 (TIGIT×PDL1 Bispecific) in Patients With Locally Advanced or Metastatic Solid Tumors'
  - id: 'NCT05023109'
    name: 'GP Chemotherapy in Combination With Anti-PD-1 and Anti-TIGIT in Unresectable Advanced BTC'
  - id: 'NCT05130177'
    name: 'Zimberelimab (AB122) With TIGIT Inhibitor Domvanalimab (AB154) in PD-1 Relapsed/Refractory Melanoma'
  - id: 'NCT04047862'
    name: 'Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors'
  - id: 'NCT05537051'
    name: 'A Study of PM1021 (Anti-TIGIT) With or Without PM8001 (Anti-PD-L1/TGF-β) in Patients With Advanced Solid Tumours'
  - id: 'NCT05019677'
    name: 'GP Chemotherapy in Combination With Tislelizumab and Ociperlimab as First-line Treatment in Advanced BTC'
  - id: 'NCT05061628'
    name: 'The Recombinant Humanized Anti-TIGIT Monoclonal Antibody (JS006) Monotherapy and in Combination With Toripalimab in Patients With Advanced Tumor'
  - id: 'NCT04656535'
    name: 'AB154 Combined With AB122 for Recurrent Glioblastoma'
  - id: 'NCT06773507'
    name: 'Phase I Study of BC008-1A Injection in Patients With Advanced Solid Tumors'
  - id: 'NCT06349980'
    name: 'A Study to Explore the Reasonable Dosage and Evaluate the Efficacy, Safety and Tolerability of HLX10 and HLX04 with or Without HLX53 in Untreated, Locally Advanced or Metastatic Hepatocellular Carcinoma Patients.'
  - id: 'NCT05706207'
    name: 'A Study of HB0030 Injection in Patients With Advanced Solid Tumors'
  - id: 'NCT05060432'
    name: 'Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors'
  - id: 'NCT06713798'
    name: 'Targeting PD-L1 and TIGIT in Tumors With Tertiary Lymphoid Structures'
  - id: 'NCT05394337'
    name: 'Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial Carcinoma'
  - id: 'NCT05253105'
    name: 'A Clinical Study of TAB006 in Patients With Previously Treated, Advanced Malignancies'
  - id: 'NCT04270942'
    name: 'At-Risk for Type 1 Diabetes Extension Study (TN-10 Extension)'
  - id: 'NCT05294952'
    name: 'co Ihibtory Receptor in Preeclampsia'
  - id: 'NCT06754501'
    name: 'A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of Dual Immune Checkpoint Inhibition With Anti-PD-L1 (Atezolizumab) and Anti-TIGIT (Tiragolumab) in Cancer of Unknown Primary'
  - id: 'NCT05757492'
    name: 'Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors'
  - id: 'NCT04952597'
    name: 'Study of Ociperlimab Plus Tislelizumab Plus Chemoradiotherapy in Participants With Untreated Limited-Stage Small Cell Lung Cancer'
  - id: 'NCT05805501'
    name: 'A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma'
  - id: 'NCT03447678'
    name: 'Pembrolizumab in First Line Treatment of Advanced NSCLC Patients With PD-L1 Low Tumors.'
  - id: 'NCT04672369'
    name: 'A Study to Evaluate the Efficacy of IBI939 in Combination With Sintilimab in Patients With Advanced NSCLC'
  - id: 'NCT04672356'
    name: 'A Study to Evaluate the Safety , Tolerability and Efficacy of IBI939 in Combination With Sintilimab in Patients With Advanced Lung Cancer'
  - id: 'NCT05009069'
    name: 'A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer'
  - id: 'NCT04353830'
    name: 'A Study Evaluating the Safety, Tolerability, and Initial Efficacy of Recombinant Human Anti-T-cell Immunoreceptor With Ig and ITIM Domains (TIGIT) Monoclonal Antibody Injection (IBI939) in Subjects With Advanced Malignant Tumors'
  - id: 'NCT07337447'
    name: 'Trial of FOLFIRI + Zimberelimab + Domvanalimab vs FOLFIRI With a Hybrid Synthetic Control Arm in Second Line Treatment of Neuroendocrine Carcinoma of Gastro-enteropancreatic or Unknown Origin (REWENEC 01)'
  - id: 'NCT04354246'
    name: 'COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies'
  - id: 'NCT04933227'
    name: 'A Study to Explore the Efficacy and Safety of Atezolizumab Plus Tiragolumab and Chemotherapy in 1st Line HER2 Negative Unresectable, Recurrent or Metastatic Gastric Cancer or Adenocarcinoma of Gastroesophageal Junction (GEJ)'
  - id: 'NCT05414032'
    name: 'Molecular Residual Disease Interception in Locoregionally-Advanced High Risk HPV+ and HPV- HNSCC'
  - id: 'NCT06003621'
    name: 'Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients'
  - id: 'NCT05568095'
    name: 'A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body'
  - id: 'NCT06777628'
    name: 'Immunophenotype of PBMC to Early Predict Response to Immunotherapy in Hepatocellular Carcinoma'
  - id: 'NCT06773481'
    name: 'BC008-1A Injection for Recurrent CNS WHO G4 Glioma'
  - id: 'NCT03708224'
    name: 'Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck'
  - id: 'NCT03652402'
    name: 'Precision Risk Stratification in Kidney Transplant Patients - EU-TRAIN'
  - id: 'NCT03486119'
    name: 'A Study for Identification of Predictive Immune Biomarker in Peripheral Blood for Nivolumab Therapy in NSCLC Patients'
  - id: 'NCT05120375'
    name: 'Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients in China'
  - id: 'NCT05327530'
    name: 'A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)'
  - id: 'NCT04570839'
    name: 'COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.'
  - id: 'NCT05520294'
    name: 'Evaluating the Effects of Cannabis Use and Circulating Cannabinoids on Tumor Infiltrating Lymphocytes in Malignant Melanoma'
  - id: 'NCT05417321'
    name: 'A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors'
  - id: 'NCT06328036'
    name: 'Testing the Combination of Anti-cancer Drugs Tiragolumab and Atezolizumab to Improve Outcomes for Patients With Recurrent Glioblastoma'
  - id: 'NCT04465643'
    name: 'Neoadjuvant Nivolumab Plus Ipilimumab for Newly Diagnosed Malignant Peripheral Nerve Sheath Tumor'
  - id: 'NCT04262856'
    name: 'Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer'
  - id: 'NCT04736173'
    name: 'Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer'
  - id: 'NCT05126537'
    name: 'Co-inhibitory Molecules on Treg and miR-155-5p in Patients With Sepsis'
  - id: 'NCT05289492'
    name: 'Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma'
  - id: 'NCT07115043'
    name: 'A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors'
  - id: 'NCT05743504'
    name: 'Immunotherapy With CCRT Followed by Surgery for Locally Advanced ESCC Patients'
  - id: 'NCT05073484'
    name: 'Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients'
  - id: 'NCT07376512'
    name: 'Predicting Response to Anti-PD-1/PD-L1 Immunotherapy by Plasma Extracellular Vesicle Analysis'
  - id: 'NCT05904886'
    name: 'A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152)'
  - id: 'NCT03739710'
    name: 'Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC)'
  - id: 'NCT04791839'
    name: 'Safety and Efficacy of Zimberelimab (AB122) in Combination With Domvanalimab (AB154) and Etrumadenant (AB928) in Patients With Previously Treated Non-Small Cell Lung Cancer'
  - id: 'NCT05020912'
    name: 'Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy'
  - id: 'NCT06334406'
    name: 'Antitumor T Cell Responses in Patients With Bladder Cancer'
  - id: 'NCT07343310'
    name: 'A First-in-Patient Clinical Trial of KINE-101 in Patients With Corticosteroid-Refractory CIDP'
  - id: 'NCT03342417'
    name: 'Combination of Nivolumab and Ipilimumab in Breast, Ovarian and Gastric Cancer Patients'
  - id: 'NCT04682665'
    name: 'Prebiotic Effect of Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver Metastases'
  - id: 'NCT05123482'
    name: 'A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies'
  - id: 'NCT07161414'
    name: 'A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy'
  - id: 'NCT07015164'
    name: 'Role of Viral Reservoir, Immune Activation and Depletion in Persistent Viremia Persistent Viremia in People Living With HIV on Antiretroviral Therapy'
  - id: 'NCT05702229'
    name: 'Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma'
  - id: 'NCT07213882'
    name: 'A Phase 1, Multicenter, Open-label, Prospective, First-in-human Dose-escalation Clinical Trial of Domain Therapeutics'' Anti-CCR8 Monoclonal Antibody (DT-7012) in Patients With Relapsed or Refractory Cutaneous T-cell Lymphomas (CTCL)'
  - id: 'NCT03628677'
    name: 'A Study to Evaluate the Safety and Tolerability of AB154 in Participants With Advanced Malignancies'
  - id: 'NCT06897436'
    name: 'Characterization of Immune Cells and Their Secreted Cytokines in Endometriosis Patients'
  - id: 'NCT05633927'
    name: 'Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in HIV-infected Patients Immunosuppressed'
  - id: 'NCT04836507'
    name: 'Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma Patients'
  - id: 'NCT05775159'
    name: 'Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer'
  - id: 'NCT06338657'
    name: 'FID-007 Followed by Standard of Care Surgery in Head and Neck Cancer'
  - id: 'NCT06860815'
    name: 'Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer'
  - id: 'NCT04624828'
    name: 'Immune Response Evaluation in Oligorecurrent and Oligoprogressive Prostate Cancer Patients Treated With SBRT'
  - id: 'NCT05574335'
    name: 'Siplizumab in T1DM'
  - id: 'NCT06302556'
    name: 'The Role of Immune Checkpoints in Lung Transplant (ILTRA)'
  - id: 'NCT04761198'
    name: 'A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors'
  - id: 'NCT04693234'
    name: 'AdvanTIG-202: Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Previously Treated Recurrent or Metastatic Cervical Cancer'
  - id: 'NCT03563716'
    name: 'A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer'
  - id: 'NCT07324642'
    name: 'A Phase 1 MAD Study of KINE-101 in Healthy Volunteers'
  - id: 'NCT05809895'
    name: 'Phase II Study Evaluating the Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Chemotherapy as First-line Treatment for Participants With Advanced Triple Negative Breast Cancer'
  - id: 'NCT04732494'
    name: 'Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma'
  - id: 'NCT05645692'
    name: 'A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT, Compared to PD-L1 Alone) in Participants With Untreated Locally Advanced Metastatic Urothelial Cancer'
  - id: 'NCT04457778'
    name: 'First in Human Study of M6223'
  - id: 'NCT03772899'
    name: 'Fecal Microbial Transplantation in Combination With Immunotherapy in Melanoma Patients (MIMic)'
  - id: 'NCT04374877'
    name: 'Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors'
  - id: 'NCT06346197'
    name: 'Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas'
  - id: 'NCT05780073'
    name: 'Safety and Impact of Dasatinib on Viral Persistence and Inflammation in People With HIV Under Antiretroviral Treatment'
  - id: 'NCT03667716'
    name: 'COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.'
  - id: 'NCT06784947'
    name: 'Trial of Atezolizumab, Bevacizumab, and Tiragolumab in Patients With Microsatellite Stable, Metastatic Colorectal Cancer'
  - id: 'NCT05014815'
    name: 'Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer'
  - id: 'NCT07307053'
    name: 'Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)'
  - id: 'NCT04746924'
    name: 'A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer'
  - id: 'NCT07098338'
    name: 'A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)'
  - id: 'NCT06532539'
    name: 'Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma'
  - id: 'NCT06864598'
    name: 'The Application of Novel Identified CD8 Regulatory Precursors in Inducing Immune Tolerance After Allo-HSCT'
  - id: 'NCT03661047'
    name: 'OMega-3 Fatty Acid for the Immune Modulation of Colorectal Cancer'
  - id: 'NCT04866017'
    name: 'A Study to Compare Ociperlimab Plus Tislelizumab Versus Durvalumab Following Concurrent Chemoradiotherapy (cCRT) in Participants With Stage III Unresectable Non-Small Cell Lung Cancer'
  - id: 'NCT05127824'
    name: 'Autologous Dendritic Cell Vaccine in Kidney Cancer'
  - id: 'NCT04303169'
    name: 'Substudy 02C: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Stage III Melanoma Who Are Candidates for Neoadjuvant Therapy (MK-3475-02C/KEYMAKER-U02)'
  - id: 'NCT05329766'
    name: 'A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies'
  - id: 'NCT04323202'
    name: 'Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N'
  - id: 'NCT07221253'
    name: 'A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)'
  - id: 'NCT05676931'
    name: 'Study With Various Immunotherapy Treatments in Participants With Lung Cancer'
  - id: 'NCT06790706'
    name: 'IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers'
  - id: 'NCT04543617'
    name: 'A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy'
  - id: 'NCT04305041'
    name: 'Substudy 02A: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents in Participants With Programmed Cell-death 1 (PD-1) Refractory Melanoma (MK-3475-02A/KEYMAKER-U02)'
  - id: 'NCT06996782'
    name: 'A Platform Study in Non-Small Cell Lung Cancer (NSCLC)'
  - id: 'NCT05665595'
    name: 'A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010)'
  - id: 'NCT06868277'
    name: 'A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer'
  - id: 'NCT06692738'
    name: 'A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)'
  - id: 'NCT04774484'
    name: 'High-Intensity Interval Training and Regulatory T Cells'
  - id: 'NCT04256421'
    name: 'A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer'
  - id: 'NCT06989112'
    name: 'DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer'
  - id: 'NCT05816460'
    name: 'The Sleepio After Cancer Study'
  - id: 'NCT06627647'
    name: 'A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC'
  - id: 'NCT04305054'
    name: 'Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanced Melanoma (MK-3475-02B/KEYMAKER-U02)'
  - id: 'NCT04294810'
    name: 'A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer'
  - id: 'NCT03198546'
    name: 'GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression'
  - id: 'NCT03198052'
    name: 'GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T Cells Against Cancers'
  - id: 'NCT04585815'
    name: 'Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study)'
  - id: 'NCT02443155'
    name: 'A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function'
